2014
DOI: 10.1021/mp500001n
|View full text |Cite
|
Sign up to set email alerts
|

Poly(ethylene glycol)-Mediated Conformational Alteration of α-Chymotrypsin Prevents Inactivation of Insulin by Stabilizing Active Intermediates

Abstract: Proteolytic enzymes in the gut represent one of the biggest barriers against oral delivery of therapeutic proteins and peptides. In the current study, we explored the effect of poly(ethylene glycol) 400 (PEG 400), a commonly used crowding agent, on insulin degradation mediated by α-chymotrypsin (α-CT). Without PEG 400, insulin was quickly cleaved by α-CT to generate inactive degradation products. In comparison, incorporation of PEG 400 resulted in reaction mixtures with retained biological activity. The analys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 44 publications
0
2
0
Order By: Relevance
“…A similar effect was observed for cholesterol oxidases (ChOx), which adsorbed onto PS/PEG particles but presented no enzymatic activity [18]. In solution the effect of PEG on the enzyme conformation and activity seems to depend on the enzyme type and on PEG molecular weight, for instance, PEG 400 changed the conformation of chymotrypsin, retarding the degradation of insulin [32], the enzymatic activity of hexokinase increased 6% in the presence of PEG 400 and decreased in the range 14%–7% in the presence of PEG 1500 and PEG 4000, respectively, due to aggregation [33], PEG 400 or 4000 presented no interaction with glucose-6-phosphate dehydrogenase (G-6-PDH), but favorable interactions were observed between PEG and the co-enzyme NADP + , which increased the enzymatic activity in 20% [34]. Comparing the activities in the presence of PEG 200, PEG 8000 or PEG 12000, the enzymatic activity of lipase increased 161% in the presence of PEG 12000 [35].…”
Section: Resultsmentioning
confidence: 78%
“…A similar effect was observed for cholesterol oxidases (ChOx), which adsorbed onto PS/PEG particles but presented no enzymatic activity [18]. In solution the effect of PEG on the enzyme conformation and activity seems to depend on the enzyme type and on PEG molecular weight, for instance, PEG 400 changed the conformation of chymotrypsin, retarding the degradation of insulin [32], the enzymatic activity of hexokinase increased 6% in the presence of PEG 400 and decreased in the range 14%–7% in the presence of PEG 1500 and PEG 4000, respectively, due to aggregation [33], PEG 400 or 4000 presented no interaction with glucose-6-phosphate dehydrogenase (G-6-PDH), but favorable interactions were observed between PEG and the co-enzyme NADP + , which increased the enzymatic activity in 20% [34]. Comparing the activities in the presence of PEG 200, PEG 8000 or PEG 12000, the enzymatic activity of lipase increased 161% in the presence of PEG 12000 [35].…”
Section: Resultsmentioning
confidence: 78%
“…Inactivation issues can be solved by the use of genetically engineered food-grade microorganisms that secrete therapeutic protein drugs (Yu et al, 2014) or by microencapsulation of the therapeutic protein drug (Shin and Yoo, 2013) to target the therapeutic proteins to the absorption site. However, because of the general large molecular size and hydrophilicity of therapeutic proteins, the issue of malabsorption is difficult to solve.…”
Section: Discussionmentioning
confidence: 99%